{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:37:13Z","timestamp":1785551833065,"version":"3.56.0"},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T00:00:00Z","timestamp":1287964800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyponatremia is a common electrolyte disorder in patients with heart failure (HF) associated with cognitive dysfunction and increased mortality and rehospitalization rates. Loop diuretics worsen renal function, produce neurohormonal activation, and induce electrolyte imbalances. Lixivaptan is a selective, oral vasopressin V<jats:sub>2<\/jats:sub>\u2010receptor antagonist that improves hyponatremia by promoting electrolyte\u2010free aquaresis without significant side effects. The Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III\/IV Cardiac Patient Evaluation (BALANCE) study is a randomized, double\u2010blind, placebo\u2010controlled, phase 3 trial designed to evaluate the effects of lixivaptan on serum sodium in patients hospitalized with worsening heart failure (target <jats:italic>N<\/jats:italic>= 650), signs of congestion and serum sodium concentrations &lt;135 mEq\/L. Other endpoints include assessment of dyspnea, body weight, cognitive function, and days of hospital\u2010free survival. Patients are randomized 1:1 to lixivaptan or matching placebo for 60 days, with a 30\u2010day safety follow\u2010up. Doses of lixivaptan or placebo are adjusted based on serum sodium and volume status. Lixivaptan was shown to increase serum sodium and reduce body weight, without renal dysfunction or hypokalemia. BALANCE seeks to address unmet questions regarding the use of vasopressin antagonists including their effects on cognitive function and clinical outcomes in patients with hyponatremia and worsening heart failure. Clin Trans Sci 2010; Volume 3: 249\u2013253.<\/jats:p>","DOI":"10.1111\/j.1752-8062.2010.00217.x","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T03:58:26Z","timestamp":1288065506000},"page":"249-253","source":"Crossref","is-referenced-by-count":24,"title":["Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III\/IV Cardiac Patient Evaluation (THE BALANCE) Study"],"prefix":"10.1111","volume":"3","author":[{"given":"William T.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Boehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Hasenfu\u03b2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marrick","family":"Kukin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Ticho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"64","volume-title":"Renaland Electrolyte Disorders","author":"Schrier RW","year":"2002"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl542"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02490-7"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.19.2581"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.73.Suppl_3.S4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.32.745"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198107303050506"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80040-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.095"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410806"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.09.001"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V103647"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00902.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.73.Suppl_3.S24"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.10.050"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065181"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000070422.41439.04"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1332"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4871-3_55"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.071"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.099313"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(03)00528-1"},{"key":"e_1_2_6_25_2","first-page":"203","article-title":"Current concepts in diastolic heart failure","volume":"108","author":"Dhar S","year":"2008","journal-title":"J Am Osteopath Assoc."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.08.005"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2466\/PMS.74.1.39-42"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1176\/jnp.18.1.54","article-title":"Neuropsychological normalization with long\u2010term atypical antipsychotic treatment: results of a six\u2010month randomized, double\u2010blind comparison of ziprasidone vs. olanzapine","volume":"18","author":"Harvey PD","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70167-4"},{"issue":"0","key":"e_1_2_6_30_2","first-page":"II\u201011\u20134","article-title":"Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery","volume":"96","author":"Hlatky MA","year":"1997","journal-title":"Circulation."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.026"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1752-8062.2010.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1752-8062.2010.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T13:51:36Z","timestamp":1697377896000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/j.1752-8062.2010.00217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1752-8062.2010.00217.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1752-8062.2010.00217.x","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}